Bevacizumab can be safely combined with FOLFOX or XELOX Journal Article
| Author: | Lichtman, S. M. |
| Article Title: | Bevacizumab can be safely combined with FOLFOX or XELOX |
| Keywords: | cancer survival; clinical trial; drug tolerability; bevacizumab; fluorouracil; placebo; cancer combination chemotherapy; cancer growth; diarrhea; drug dose reduction; drug efficacy; drug safety; drug withdrawal; hypertension; monotherapy; note; capecitabine; colorectal cancer; metastasis; quality of life; antineoplastic activity; irinotecan; folinic acid; drug response; intestine perforation; oxaliplatin; hand foot syndrome; dose calculation |
| Journal Title: | The Oncology Report |
| Issue: | Spring |
| ISSN: | 1548-5323 |
| Publisher: | International Medical News Group LLC |
| Date Published: | 2005-03-01 |
| Start Page: | 43 |
| End Page: | 44 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 24 October 2012" - "Source: Scopus" |
MSK Authors
-
228Lichtman